Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Eli Lilly

California latest to sue drug companies over insulin prices

California says it will sue the companies that make and promote much of the nation's insulin

The Independent UK

2023 could be a banner year for prescription drugs

There's a large pipeline of promising yet expensive drugs that could get approved.

Axios

Tesla share plunge puts market cap behind LVMH, Nvidia, Eli Lilly

Tesla shares fell 12.2% on Tuesday after missing expectations on fourth-quarter deliveries.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

Axios

Twitter to re-launch blue tick subscription service after first chaotic rollout backfired

The platform’s Blue subscriptions will return with $8 monthly charges, or $11 a month for iPhone users

The Independent UK

Top executives explain how they achieve ESG goals amid backlash

How should companies reframe ESG initiatives amid controversy? These executives offer their strategies.

Fortune

Twitter has lost 50 of its top 100 advertisers since Elon Musk took over, report says

Half of Twitter's top 100 advertisers appear to no longer be advertising on the website. A new report states that these 50 advertisers have spent almost $2 billion on Twitter ads since 2020.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Elon Musk's Twitter Blue fiasco: Governments need to better regulate how companies use trademarks

Until recently, Twitter’s blue checkmark logo was (for better or worse) a trusted mark of authenticity. But under the façade of democratizing the platform, Elon Musk allowed the blue checkmark to be purchased by anyone — with unsurprisingly chaotic results.

The Conversation

‘More work to do’: Eli Lilly admits insulin pricing could be lower amid Twitter chaos

Furor over platform’s verified profiles may have done some good, but challenges still plague the site after a mass worker exodus

The Guardian - US

Impersonation and parody: Shitposters satirically mock Elon Musk’s chaotic Twitter takeover

Posting on Twitter has changed since Elon Musk finalized his $44 billion takeover of the micro-blogging platform.

The Conversation

Profit, privacy and online safety: What's at stake with Twitter verification

The past week has seen Twitter announce – and quickly retract – new rules for authenticating user profiles, notably a controversial proposal to offer “blue check” verification to anyone willing to pay $8 a month. New owner Elon Musk, who on Tuesday set November 29 as the scheme’s relaunch date,…

France 24

Balenciaga becomes the first major brand to delete its Twitter account

Fashion house Balenciaga has become the first brand to delete its Twitter account since the Musk acquisition.

Fortune

Twitter Prank Spurs Unexpected Scrutiny of Insulin Prices

A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis -- a new wave of scrutiny of the high cost of its insulin. Authentic-looking fake accounts proliferated last week after Twitter rolled out a paid verification service, the latest in a…

Asharq Al-Awsat

These Stocks Are Still Feeling The Heat From Elon Musk's Twitter Blue Dumpster Fire

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk kicked off his first week at the helm of Twitter with a bang — but it backfired.<

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Elon Musk fans spend £500,000 on GOAT monument in honour of controversial Twitter owner

The world's richest man will be presented with the statue at his Tesla HQ in Austin, Texas, next month

Fortune

Musk says Twitter Blue will ‘probably’ return by the ‘end of next week’ after trolling of companies, celebs by imposters

Pranked companies like Eli Lilly and Lockheed Martin will no doubt be watching closely.

ABC News

Pharmaceutical giant Eli Lilly & Co apologises after fake Twitter account says insulin is free as Elon Musk rolls back verification

The incident is among a wave of impersonations that prompted Twitter to make its relaunched premium service unavailable.

Fortune

No, insulin is not free: Eli Lilly is the latest high-profile casualty of Elon Musk’s Twitter verification mess

Eli Lilly shares fell after pranksters using Twitter Blue impersonated it and made a surprising claim—and this might be just the beginning.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Pharmaceutical companies’ stocks dive after verified imposter Twitter account claims ‘insulin is free’

Insulin producers Eli Lilly, Novo Nordisk and Sanofi all reported losses during Friday’s trading

Benzinga

Block, Eli Lilly And 2 Other Stocks Insiders Are Selling

The US economy added 261,000 jobs in October, while the unemployment rate increased to 3.7% during the month. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 50 points on Tuesday.

Benzinga

Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization Next Year: Top Stories Tuesday, Nov. 1

Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production

Benzinga

Eli Lilly Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 21 strange trades.

Benzinga

This Is What Whales Are Betting On Eli Lilly

Someone with a lot of money to spend has taken a bullish stance on Eli Lilly (NYSE:LLY). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

New Drugs Approvals Bring No Relief for Ailing Innovent Bio

Key Takeaways: Innovent Bio has brought several drugs to market in recent years, including two announced last week, but is still losing money with no profits in sight The company has overhauled its commercialization model and is doing more licensing partnerships with multinationals to expand its drug pipeline By Molly…

1 … 23 24 25 26

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.